Activation of Cytotoxic Natural Killer Cells after Aneurysmal Subarachnoid Haemorrhage

Abstract Objective Cell-mediated inflammation is critical in development of cerebrovascular complications after aneurysmal subarachnoid haemorrhage (aSAH). We analysed the course for activated CD16bright CD56dim cytotoxic NKCSF cells (NK) in cerebrospinal fluid (CSF) of 15 patients. Methods Patients...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:World neurosurgery 2017-05, Vol.101, p.666-676.e1
Hauptverfasser: Spitzer, Daniel, Dr. med, Johanna Spitzer, Nina, Deininger, Monika, Rainer Wirtz, Christian, Prof. Dr. med, König, Ralph, Prof. Dr. med, Burster, Timo, PD Dr. rer. nat, Kapapa, Thomas, PD Dr. med
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 676.e1
container_issue
container_start_page 666
container_title World neurosurgery
container_volume 101
creator Spitzer, Daniel, Dr. med
Johanna Spitzer, Nina
Deininger, Monika
Rainer Wirtz, Christian, Prof. Dr. med
König, Ralph, Prof. Dr. med
Burster, Timo, PD Dr. rer. nat
Kapapa, Thomas, PD Dr. med
description Abstract Objective Cell-mediated inflammation is critical in development of cerebrovascular complications after aneurysmal subarachnoid haemorrhage (aSAH). We analysed the course for activated CD16bright CD56dim cytotoxic NKCSF cells (NK) in cerebrospinal fluid (CSF) of 15 patients. Methods Patients were classified by occurrence of cerebral vasospasm and delayed cerebral ischemia. NK were monitored by flow cytometry between day 1 and 14 after haemorrhage. Results 12 (80%) patients developed CV with a mean day of detection at 3.9±1.6. In those cell count for NK increased from 1.40±1.42 cells/μl on day 1 to a peak of 11.66±11.56 cells/μl on day 6.1±2.9 (p=0.001). An increase of mean CBFV in TCD from 71.33±12.93 cm/sec. to 166.20±20.19 cm/sec. (p
doi_str_mv 10.1016/j.wneu.2017.03.026
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1879662134</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1878875017303388</els_id><sourcerecordid>1879662134</sourcerecordid><originalsourceid>FETCH-LOGICAL-c411t-26ac4b20f470c0ce49f9168d3791e4b5e8e6dd0d0b411ab1c4fd587f07d42c8e3</originalsourceid><addsrcrecordid>eNp9kU9v1DAQxS1ERau2X4ADypHLpuM_GzsSQlqtoEVUcChwtRx7Qr0kcbGdlv32dbSlBw744pH83hvPbwh5TaGmQJuLXf0w4VwzoLIGXgNrXpATqqRaKdm0L5_rNRyT85R2UA6nQkn-ihwzxRkvghPyY2OzvzfZh6kKfbXd55DDH2-rLybP0QzVZz8MGKstDkOqTJ9LvSmN4z6N5fVm7kw09nYK3lVXBscQ4635iWfkqDdDwvOn-5R8__jh2_Zqdf318tN2c72ygtK8Yo2xomPQCwkWLIq2b2mjHJctRdGtUWHjHDjoitx01IrerZXsQTrBrEJ-St4ecu9i-D1jynr0yZa_mgnDnHSZsW0aRrkoUnaQ2hhSitjru-hHE_eagl6Q6p1ekOoFqQauC9JievOUP3cjumfLX4BF8O4gwDLlvceok_U4WXQ-os3aBf___Pf_2O3gJ2_N8Av3mHZhjlPhp6lOTIO-WZa67JRKDpwrxR8BsvedNw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1879662134</pqid></control><display><type>article</type><title>Activation of Cytotoxic Natural Killer Cells after Aneurysmal Subarachnoid Haemorrhage</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Spitzer, Daniel, Dr. med ; Johanna Spitzer, Nina ; Deininger, Monika ; Rainer Wirtz, Christian, Prof. Dr. med ; König, Ralph, Prof. Dr. med ; Burster, Timo, PD Dr. rer. nat ; Kapapa, Thomas, PD Dr. med</creator><creatorcontrib>Spitzer, Daniel, Dr. med ; Johanna Spitzer, Nina ; Deininger, Monika ; Rainer Wirtz, Christian, Prof. Dr. med ; König, Ralph, Prof. Dr. med ; Burster, Timo, PD Dr. rer. nat ; Kapapa, Thomas, PD Dr. med</creatorcontrib><description>Abstract Objective Cell-mediated inflammation is critical in development of cerebrovascular complications after aneurysmal subarachnoid haemorrhage (aSAH). We analysed the course for activated CD16bright CD56dim cytotoxic NKCSF cells (NK) in cerebrospinal fluid (CSF) of 15 patients. Methods Patients were classified by occurrence of cerebral vasospasm and delayed cerebral ischemia. NK were monitored by flow cytometry between day 1 and 14 after haemorrhage. Results 12 (80%) patients developed CV with a mean day of detection at 3.9±1.6. In those cell count for NK increased from 1.40±1.42 cells/μl on day 1 to a peak of 11.66±11.56 cells/μl on day 6.1±2.9 (p=0.001). An increase of mean CBFV in TCD from 71.33±12.93 cm/sec. to 166.20±20.19 cm/sec. (p&lt;0.01) and an increase in number of vascular axes affected by CV was detected (p&lt;0.01). In patients with grade 3 CV (n=4, 33.3%) activated NK counts were significantly higher than in non-CV patients (23.18±13.92 cells/μl versus 0.02±0.01 cells/μl; p=0.029). NK counts were significantly different between patients with grade 1 and grade 3 CV (p=0.04). Non-CV patients who demonstrated low NK counts achieved better functional outcome (GOS 4.6±0.6) at discharge than patients with CV grade 2 (GOS 3.3±0.5) and CV grade 3 (GOS 2.3±0.5) who demonstrated elevated NKC counts (CV grade 0 versus CV grade 2, p=0.048; CV grade 0 versus CV grade 3, p=0.001). Activated CD16bright CD56dim cytotoxic NKCSF cell counts revealed a mean maximum (14.15±12.21 cells/μl) when DCI occurred. Conclusion The increase of activated CD16bright CD56dim cytotoxic NK cells in CSF after aSAH suggests an increased risk of CV and DCI.</description><identifier>ISSN: 1878-8750</identifier><identifier>EISSN: 1878-8769</identifier><identifier>DOI: 10.1016/j.wneu.2017.03.026</identifier><identifier>PMID: 28323187</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Angiography ; Cytotoxicity, Immunologic - physiology ; Delayed cerebral ischemia ; Female ; Humans ; Infarction ; Inflammation ; Killer Cells, Natural - immunology ; Killer Cells, Natural - metabolism ; Male ; Middle Aged ; Neurosurgery ; Outcome ; Prospective Studies ; Subarachnoid Hemorrhage - immunology ; Subarachnoid Hemorrhage - metabolism ; Vasospasm, Intracranial - immunology ; Vasospasm, Intracranial - metabolism</subject><ispartof>World neurosurgery, 2017-05, Vol.101, p.666-676.e1</ispartof><rights>Elsevier Inc.</rights><rights>2017 Elsevier Inc.</rights><rights>Copyright © 2017 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c411t-26ac4b20f470c0ce49f9168d3791e4b5e8e6dd0d0b411ab1c4fd587f07d42c8e3</citedby><cites>FETCH-LOGICAL-c411t-26ac4b20f470c0ce49f9168d3791e4b5e8e6dd0d0b411ab1c4fd587f07d42c8e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1878875017303388$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28323187$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Spitzer, Daniel, Dr. med</creatorcontrib><creatorcontrib>Johanna Spitzer, Nina</creatorcontrib><creatorcontrib>Deininger, Monika</creatorcontrib><creatorcontrib>Rainer Wirtz, Christian, Prof. Dr. med</creatorcontrib><creatorcontrib>König, Ralph, Prof. Dr. med</creatorcontrib><creatorcontrib>Burster, Timo, PD Dr. rer. nat</creatorcontrib><creatorcontrib>Kapapa, Thomas, PD Dr. med</creatorcontrib><title>Activation of Cytotoxic Natural Killer Cells after Aneurysmal Subarachnoid Haemorrhage</title><title>World neurosurgery</title><addtitle>World Neurosurg</addtitle><description>Abstract Objective Cell-mediated inflammation is critical in development of cerebrovascular complications after aneurysmal subarachnoid haemorrhage (aSAH). We analysed the course for activated CD16bright CD56dim cytotoxic NKCSF cells (NK) in cerebrospinal fluid (CSF) of 15 patients. Methods Patients were classified by occurrence of cerebral vasospasm and delayed cerebral ischemia. NK were monitored by flow cytometry between day 1 and 14 after haemorrhage. Results 12 (80%) patients developed CV with a mean day of detection at 3.9±1.6. In those cell count for NK increased from 1.40±1.42 cells/μl on day 1 to a peak of 11.66±11.56 cells/μl on day 6.1±2.9 (p=0.001). An increase of mean CBFV in TCD from 71.33±12.93 cm/sec. to 166.20±20.19 cm/sec. (p&lt;0.01) and an increase in number of vascular axes affected by CV was detected (p&lt;0.01). In patients with grade 3 CV (n=4, 33.3%) activated NK counts were significantly higher than in non-CV patients (23.18±13.92 cells/μl versus 0.02±0.01 cells/μl; p=0.029). NK counts were significantly different between patients with grade 1 and grade 3 CV (p=0.04). Non-CV patients who demonstrated low NK counts achieved better functional outcome (GOS 4.6±0.6) at discharge than patients with CV grade 2 (GOS 3.3±0.5) and CV grade 3 (GOS 2.3±0.5) who demonstrated elevated NKC counts (CV grade 0 versus CV grade 2, p=0.048; CV grade 0 versus CV grade 3, p=0.001). Activated CD16bright CD56dim cytotoxic NKCSF cell counts revealed a mean maximum (14.15±12.21 cells/μl) when DCI occurred. Conclusion The increase of activated CD16bright CD56dim cytotoxic NK cells in CSF after aSAH suggests an increased risk of CV and DCI.</description><subject>Adult</subject><subject>Angiography</subject><subject>Cytotoxicity, Immunologic - physiology</subject><subject>Delayed cerebral ischemia</subject><subject>Female</subject><subject>Humans</subject><subject>Infarction</subject><subject>Inflammation</subject><subject>Killer Cells, Natural - immunology</subject><subject>Killer Cells, Natural - metabolism</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neurosurgery</subject><subject>Outcome</subject><subject>Prospective Studies</subject><subject>Subarachnoid Hemorrhage - immunology</subject><subject>Subarachnoid Hemorrhage - metabolism</subject><subject>Vasospasm, Intracranial - immunology</subject><subject>Vasospasm, Intracranial - metabolism</subject><issn>1878-8750</issn><issn>1878-8769</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU9v1DAQxS1ERau2X4ADypHLpuM_GzsSQlqtoEVUcChwtRx7Qr0kcbGdlv32dbSlBw744pH83hvPbwh5TaGmQJuLXf0w4VwzoLIGXgNrXpATqqRaKdm0L5_rNRyT85R2UA6nQkn-ihwzxRkvghPyY2OzvzfZh6kKfbXd55DDH2-rLybP0QzVZz8MGKstDkOqTJ9LvSmN4z6N5fVm7kw09nYK3lVXBscQ4635iWfkqDdDwvOn-5R8__jh2_Zqdf318tN2c72ygtK8Yo2xomPQCwkWLIq2b2mjHJctRdGtUWHjHDjoitx01IrerZXsQTrBrEJ-St4ecu9i-D1jynr0yZa_mgnDnHSZsW0aRrkoUnaQ2hhSitjru-hHE_eagl6Q6p1ekOoFqQauC9JievOUP3cjumfLX4BF8O4gwDLlvceok_U4WXQ-os3aBf___Pf_2O3gJ2_N8Av3mHZhjlPhp6lOTIO-WZa67JRKDpwrxR8BsvedNw</recordid><startdate>20170501</startdate><enddate>20170501</enddate><creator>Spitzer, Daniel, Dr. med</creator><creator>Johanna Spitzer, Nina</creator><creator>Deininger, Monika</creator><creator>Rainer Wirtz, Christian, Prof. Dr. med</creator><creator>König, Ralph, Prof. Dr. med</creator><creator>Burster, Timo, PD Dr. rer. nat</creator><creator>Kapapa, Thomas, PD Dr. med</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170501</creationdate><title>Activation of Cytotoxic Natural Killer Cells after Aneurysmal Subarachnoid Haemorrhage</title><author>Spitzer, Daniel, Dr. med ; Johanna Spitzer, Nina ; Deininger, Monika ; Rainer Wirtz, Christian, Prof. Dr. med ; König, Ralph, Prof. Dr. med ; Burster, Timo, PD Dr. rer. nat ; Kapapa, Thomas, PD Dr. med</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c411t-26ac4b20f470c0ce49f9168d3791e4b5e8e6dd0d0b411ab1c4fd587f07d42c8e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adult</topic><topic>Angiography</topic><topic>Cytotoxicity, Immunologic - physiology</topic><topic>Delayed cerebral ischemia</topic><topic>Female</topic><topic>Humans</topic><topic>Infarction</topic><topic>Inflammation</topic><topic>Killer Cells, Natural - immunology</topic><topic>Killer Cells, Natural - metabolism</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neurosurgery</topic><topic>Outcome</topic><topic>Prospective Studies</topic><topic>Subarachnoid Hemorrhage - immunology</topic><topic>Subarachnoid Hemorrhage - metabolism</topic><topic>Vasospasm, Intracranial - immunology</topic><topic>Vasospasm, Intracranial - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Spitzer, Daniel, Dr. med</creatorcontrib><creatorcontrib>Johanna Spitzer, Nina</creatorcontrib><creatorcontrib>Deininger, Monika</creatorcontrib><creatorcontrib>Rainer Wirtz, Christian, Prof. Dr. med</creatorcontrib><creatorcontrib>König, Ralph, Prof. Dr. med</creatorcontrib><creatorcontrib>Burster, Timo, PD Dr. rer. nat</creatorcontrib><creatorcontrib>Kapapa, Thomas, PD Dr. med</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>World neurosurgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Spitzer, Daniel, Dr. med</au><au>Johanna Spitzer, Nina</au><au>Deininger, Monika</au><au>Rainer Wirtz, Christian, Prof. Dr. med</au><au>König, Ralph, Prof. Dr. med</au><au>Burster, Timo, PD Dr. rer. nat</au><au>Kapapa, Thomas, PD Dr. med</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Activation of Cytotoxic Natural Killer Cells after Aneurysmal Subarachnoid Haemorrhage</atitle><jtitle>World neurosurgery</jtitle><addtitle>World Neurosurg</addtitle><date>2017-05-01</date><risdate>2017</risdate><volume>101</volume><spage>666</spage><epage>676.e1</epage><pages>666-676.e1</pages><issn>1878-8750</issn><eissn>1878-8769</eissn><abstract>Abstract Objective Cell-mediated inflammation is critical in development of cerebrovascular complications after aneurysmal subarachnoid haemorrhage (aSAH). We analysed the course for activated CD16bright CD56dim cytotoxic NKCSF cells (NK) in cerebrospinal fluid (CSF) of 15 patients. Methods Patients were classified by occurrence of cerebral vasospasm and delayed cerebral ischemia. NK were monitored by flow cytometry between day 1 and 14 after haemorrhage. Results 12 (80%) patients developed CV with a mean day of detection at 3.9±1.6. In those cell count for NK increased from 1.40±1.42 cells/μl on day 1 to a peak of 11.66±11.56 cells/μl on day 6.1±2.9 (p=0.001). An increase of mean CBFV in TCD from 71.33±12.93 cm/sec. to 166.20±20.19 cm/sec. (p&lt;0.01) and an increase in number of vascular axes affected by CV was detected (p&lt;0.01). In patients with grade 3 CV (n=4, 33.3%) activated NK counts were significantly higher than in non-CV patients (23.18±13.92 cells/μl versus 0.02±0.01 cells/μl; p=0.029). NK counts were significantly different between patients with grade 1 and grade 3 CV (p=0.04). Non-CV patients who demonstrated low NK counts achieved better functional outcome (GOS 4.6±0.6) at discharge than patients with CV grade 2 (GOS 3.3±0.5) and CV grade 3 (GOS 2.3±0.5) who demonstrated elevated NKC counts (CV grade 0 versus CV grade 2, p=0.048; CV grade 0 versus CV grade 3, p=0.001). Activated CD16bright CD56dim cytotoxic NKCSF cell counts revealed a mean maximum (14.15±12.21 cells/μl) when DCI occurred. Conclusion The increase of activated CD16bright CD56dim cytotoxic NK cells in CSF after aSAH suggests an increased risk of CV and DCI.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>28323187</pmid><doi>10.1016/j.wneu.2017.03.026</doi></addata></record>
fulltext fulltext
identifier ISSN: 1878-8750
ispartof World neurosurgery, 2017-05, Vol.101, p.666-676.e1
issn 1878-8750
1878-8769
language eng
recordid cdi_proquest_miscellaneous_1879662134
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adult
Angiography
Cytotoxicity, Immunologic - physiology
Delayed cerebral ischemia
Female
Humans
Infarction
Inflammation
Killer Cells, Natural - immunology
Killer Cells, Natural - metabolism
Male
Middle Aged
Neurosurgery
Outcome
Prospective Studies
Subarachnoid Hemorrhage - immunology
Subarachnoid Hemorrhage - metabolism
Vasospasm, Intracranial - immunology
Vasospasm, Intracranial - metabolism
title Activation of Cytotoxic Natural Killer Cells after Aneurysmal Subarachnoid Haemorrhage
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T16%3A16%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Activation%20of%20Cytotoxic%20Natural%20Killer%20Cells%20after%20Aneurysmal%20Subarachnoid%20Haemorrhage&rft.jtitle=World%20neurosurgery&rft.au=Spitzer,%20Daniel,%20Dr.%20med&rft.date=2017-05-01&rft.volume=101&rft.spage=666&rft.epage=676.e1&rft.pages=666-676.e1&rft.issn=1878-8750&rft.eissn=1878-8769&rft_id=info:doi/10.1016/j.wneu.2017.03.026&rft_dat=%3Cproquest_cross%3E1879662134%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1879662134&rft_id=info:pmid/28323187&rft_els_id=S1878875017303388&rfr_iscdi=true